NCT07762625

Brief Summary

The goal of this clinical trial is to evaluate the effects of a couple-based collaborative lifestyle intervention among women with a history of gestational diabetes. The main questions it aims to answer are: Does the intervention improve body mass index and 2-hour plasma glucose after an oral glucose tolerance test? Does the intervention improve health behaviors, psychological well-being, self-efficacy, couple functioning, and life satisfaction? Researchers will compare a couple-based collaborative lifestyle intervention with a woman-only lifestyle intervention to determine whether adding spousal collaboration and support leads to greater improvements. Participants will: Receive healthy lifestyle education posts for 3 months. In the couple-based group, also receive instant messages on behavioral promotion and couple collaboration and support videos.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
362

participants targeted

Target at P75+ for not_applicable

Timeline
25mo left

Started Aug 2026

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 8, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 13, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

August 15, 2026

Expected
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2028

Last Updated

August 13, 2026

Status Verified

August 1, 2026

Enrollment Period

2 years

First QC Date

August 8, 2026

Last Update Submit

August 8, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • 2 h Oral Glucose Tolerance Test

    Two-hour plasma glucose will be measured 2 hours after a 75-g oral glucose load during an oral glucose tolerance test and reported in mmol/L.

    Baseline and 6 months

  • Body Mass Index

    Body mass index will be calculated as weight in kilograms divided by height in meters squared (kg/m²).

    Baseline, 3 months, and 6 months

Secondary Outcomes (16)

  • Fasting Blood Glucose

    Baseline and 6 months

  • Total Cholesterol

    Baseline and 6 months

  • Triglycerides

    Baseline and 6 months

  • High-Density Lipoprotein Cholesterol

    Baseline and 6 months

  • Low-Density Lipoprotein Cholesterol

    Baseline and 6 months

  • +11 more secondary outcomes

Study Arms (2)

Couple-based Collaborative Lifestyle Intervention arm

EXPERIMENTAL

Women with a history of gestational diabetes and their spouses will receive a 3-month couple-based lifestyle intervention consisting of health modules delivered through health education posts, instant messages, and short videos.

Behavioral: Couple-based Collaborative Lifestyle Intervention

Woman-only Lifestyle Intervention arm

ACTIVE COMPARATOR

Women with a history of gestational diabetes will receive a 3-month lifestyle intervention delivered through health education posts, without the couple collaboration and support components (instant messages, and short videos).

Behavioral: Woman-only Lifestyle Intervention

Interventions

Couples will receive a 3-month lifestyle intervention delivered through health education posts, short videos, and instant messages. The intervention addresses healthy diet, physical activity, and stress management, with smoking cessation and alcohol reduction provided when applicable. Couple-specific components focus on role allocation, couple communication, and time management.

Couple-based Collaborative Lifestyle Intervention arm

Women will receive a 3-month lifestyle intervention delivered through health education posts focusing on healthy diet, physical activity, and stress management, with smoking cessation and alcohol reduction provided when applicable. The intervention does not include the couple collaboration and support components provided in the experimental group.

Woman-only Lifestyle Intervention arm

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • For women:
  • to 40 years of age.
  • Diagnosed with gestational diabetes mellitus during the most recent pregnancy.
  • Have basic literacy and sufficient cognitive and physical ability to participate in the study.
  • Living with their spouse.
  • Able to use a smartphone.
  • Willing to participate in the study.
  • For spouses:
  • Living with an eligible woman with a history of gestational diabetes mellitus.
  • Have basic literacy and sufficient cognitive and physical ability to participate in the study.
  • Able to use a smartphone.
  • Willing to participate in the study.

You may not qualify if:

  • For women:
  • Diabetes diagnosed before pregnancy or after delivery.
  • Pregnant at the time of screening.
  • Currently using medications that affect glucose metabolism or medications for weight loss.
  • Cognitive impairment or a serious psychiatric disorder.
  • A contraindication to postpartum exercise.
  • Current participation in another lifestyle intervention program.
  • For spouses:
  • A diagnosed major chronic disease, such as coronary heart disease or diabetes, or another serious physical illness.
  • Cognitive impairment or a serious psychiatric disorder.
  • Current participation in another lifestyle intervention program.
  • Women with a history of gestational diabetes mellitus and their spouses will be recruited during postpartum follow-up visits at the participating hospitals. Both members of the couple must meet their respective eligibility criteria.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Changde First People's Hospital

Changde, Hunan, 415003, China

Location

Changsha Central Hospital

Changsha, Hunan, 410004, China

Location

General Hospital of Hunan University of Medicine

Huaihua, Hunan, 418000, China

Location

Study Officials

  • Chunxia Cheng

    The Third Xiangya Hospital of Central South University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Physician

Study Record Dates

First Submitted

August 8, 2026

First Posted

August 13, 2026

Study Start (Estimated)

August 15, 2026

Primary Completion (Estimated)

August 30, 2028

Study Completion (Estimated)

August 30, 2028

Last Updated

August 13, 2026

Record last verified: 2026-08

Locations